Wells Fargo & Company Keros Therapeutics, Inc. Transaction History

Wells Fargo & Company

  • $433 Billion
  • Q4 2024

A detailed history of Wells Fargo & Company transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 15,208 shares of KROS stock, worth $170,633. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,208
Previous 11,055 37.57%
Holding current value
$170,633
Previous $641,000 62.56%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$15.64 - $70.0 $64,952 - $290,710
4,153 Added 37.57%
15,208 $240,000
Q3 2024

Nov 13, 2024
SELL
$41.68 - $58.07 $19,339 - $26,944
-464 Reduced 4.03%
11,055 $641,000
Q2 2024

Aug 13, 2024
BUY
$44.58 - $66.89 $98,521 - $147,826
2,210 Added 23.74%
11,519 $526,000
Q1 2024

May 10, 2024
BUY
$41.26 - $70.48 $138,757 - $237,024
3,363 Added 56.56%
9,309 $616,000
Q4 2023

Feb 09, 2024
SELL
$27.12 - $41.05 $251,999 - $381,436
-9,292 Reduced 60.98%
5,946 $236,000
Q3 2023

Nov 13, 2023
SELL
$31.57 - $43.02 $192,103 - $261,776
-6,085 Reduced 28.54%
15,238 $485,000
Q2 2023

Aug 15, 2023
BUY
$37.26 - $51.01 $261,416 - $357,886
7,016 Added 49.04%
21,323 $856,000
Q1 2023

May 12, 2023
BUY
$41.44 - $59.32 $590,934 - $845,903
14,260 Added 30340.43%
14,307 $610,000
Q4 2022

Feb 13, 2023
SELL
$39.45 - $51.77 $24,380 - $31,993
-618 Reduced 92.93%
47 $2,000
Q3 2022

Nov 14, 2022
SELL
$27.8 - $40.12 $97,633 - $140,901
-3,512 Reduced 84.08%
665 $25,000
Q2 2022

Aug 12, 2022
BUY
$26.03 - $67.04 $70,124 - $180,605
2,694 Added 181.66%
4,177 $115,000
Q1 2022

May 16, 2022
SELL
$42.12 - $59.36 $225,384 - $317,635
-5,351 Reduced 78.3%
1,483 $81,000
Q4 2021

Feb 14, 2022
BUY
$36.95 - $62.89 $252,405 - $429,601
6,831 Added 227700.0%
6,834 $400,000
Q3 2021

Nov 15, 2021
SELL
$29.27 - $43.71 $175 - $262
-6 Reduced 66.67%
3 $0
Q2 2021

Aug 16, 2021
SELL
$42.4 - $70.11 $17,892 - $29,586
-422 Reduced 97.91%
9 $0
Q1 2021

May 13, 2021
SELL
$54.0 - $75.28 $1.03 Million - $1.44 Million
-19,083 Reduced 97.79%
431 $27,000
Q4 2020

Feb 09, 2021
BUY
$36.0 - $82.74 $251,712 - $578,518
6,992 Added 55.84%
19,514 $1.38 Million
Q3 2020

Nov 05, 2020
BUY
$27.04 - $62.21 $13,492 - $31,042
499 Added 4.15%
12,522 $483,000
Q2 2020

Aug 13, 2020
BUY
$20.08 - $40.39 $241,421 - $485,608
12,023 New
12,023 $451,000

Others Institutions Holding KROS

# of Institutions
177
Shares Held
31.1M
Call Options Held
646K
Put Options Held
670K
View Full List

About Keros Therapeutics, Inc.

KROS Quotes by TradingView
  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $289M
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email